Search


Leveraging enzymes to help scale RNA therapies and other biocatalyst use cases with the CEO of Codexis
Stephen Dilly describes how Codexis is trying help RNA companies use enzymes to more efficiently make oligonucleotides.
Dec 21, 2023
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.